Vivos Therapeutics Inc./$VVOS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Ticker
$VVOS
Sector
Primary listing
Employees
113
Headquarters
Website
VVOS Metrics
BasicAdvanced
$35M
-
-$1.78
7.00
-
Price and volume
Market cap
$35M
Beta
7
52-week high
$7.95
52-week low
$1.98
Average daily volume
196K
Financial strength
Current ratio
1.047
Quick ratio
0.939
Long term debt to equity
233.799
Total debt to equity
252.695
Profitability
EBITDA (TTM)
-13.459
Gross margin (TTM)
55.91%
Net profit margin (TTM)
-99.50%
Operating margin (TTM)
-98.88%
Revenue per employee (TTM)
$130,000
Management effectiveness
Return on assets (TTM)
-42.48%
Return on equity (TTM)
-262.05%
Valuation
Price to revenue (TTM)
2.589
Price to book
7.39
Price to tangible book (TTM)
-5.56
Price to free cash flow (TTM)
-2.378
Free cash flow yield (TTM)
-42.05%
Free cash flow per share (TTM)
-1.945
Growth
Revenue change (TTM)
2.65%
Earnings per share change (TTM)
-69.91%
3-year revenue growth (CAGR)
-4.96%
3-year earnings per share growth (CAGR)
-60.32%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Vivos Therapeutics Inc. stock?
Vivos Therapeutics Inc. (VVOS) has a market cap of $35M as of August 26, 2025.
What is the P/E ratio for Vivos Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Vivos Therapeutics Inc. (VVOS) stock is 0 as of August 26, 2025.
Does Vivos Therapeutics Inc. stock pay dividends?
No, Vivos Therapeutics Inc. (VVOS) stock does not pay dividends to its shareholders as of August 26, 2025.
When is the next Vivos Therapeutics Inc. dividend payment date?
Vivos Therapeutics Inc. (VVOS) stock does not pay dividends to its shareholders.
What is the beta indicator for Vivos Therapeutics Inc.?
Vivos Therapeutics Inc. (VVOS) has a beta rating of 7. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.